on 06 Sep 2019
Last Applicant/ Owned by
CH-4123 Allschwil
CH
Serial Number
79051641 filed on 01st Feb 2008
Registration Number
3570254 registered on 03rd Feb 2009
Correspondent Address
SCOTT D. WOLDOW
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Pharmaceutical anti-allergic preparations and substances, Pharmaceutical for the treatment of erectile dysfunction, Pharmaceutical preparations, namely, anticoagulants, Pharmaceutical preparations, namely, antidepressants, Pharmaceutical preparations, namely, appetite suppressants, Pharmaceutical preparations for use in chemotherapy, Pharmaceutical preparation for the treatment of gout, Pharmaceut Read More
[ Chemicals for use in industry and science; chemical preparations for use in agriculture, namely, chemical preparations for the treatment of seeds; and chemical preparations for use in photography, namely, chemical developers; unprocessed artificial resins as raw materials in the form of powders, liquids or pastes; unprocessed plastics for industrial use; unprocessed plastics in all forms; fertilizers, namely, manures; fire extinguishing compositions; tempering chemicals for use in metalworking or soldering; chemical substances for preserving foodstuffs; tanning agents for use in the manufacture of leather, adhesives for general industrial use ]
[ Bleaching preparations for household use; general purpose cleaning, polishing, scouring and abrasive liquids and powders; soaps; perfumery, essential oils for personal use and for use as ingredients in the manufacture of cosmetic preparations; cosmetics; hair lotions; dentifrices ]
Pharmaceutical anti-allergic preparations and substances, Pharmaceutical for the treatment of erectile dysfunction, Pharmaceutical preparations, namely, anticoagulants, Pharmaceutical preparations, namely, antidepressants, Pharmaceutical preparations, namely, appetite suppressants, Pharmaceutical preparations for use in chemotherapy, Pharmaceutical preparation for the treatment of gout, Pharmaceutical preparations for the treatment of heart rhythm disorders, Pharmaceutical preparations for the treatment of stem cell mobilization, Pharmaceutical preparations for the treatment of infectious diseases, Pharmaceutical preparations acting on the central nervous system, Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, Pharmaceutical preparations for animal skincare, Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension, Pharmaceutical preparations for ocular or intraocular surgery, Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, Pharmaceutical preparations for treating allergic rhinitis and asthma, Pharmaceutical preparations for treating diabetes, Pharmaceutical preparations for treating skin disorders, Pharmaceutical preparations for use in dermatology, Pharmaceutical preparations for wounds, Pharmaceutical preparations for use in urology, Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine, Pharmaceutical products and preparations against dry skin caused by pregnancy, Pharmaceutical products and preparations for chloasma, Pharmaceutical products and preparations for hydrating the skin during pregnancy, Pharmaceutical products and preparations for pregnancy blemishes, Pharmaceutical products and preparations for preventing skin blemishes during pregnancy, Pharmaceutical products and preparations to prevent stretch marks, Pharmaceutical products and preparations to prevent swelling in the legs, Pharmaceutical products for ophthalmological use, Pharmaceutical products for skin care for animals, Pharmaceutical products for the treatment of bone diseases, Pharmaceutical products for the treatment of viral and infectious diseases and for the treatment of cancer, Pharmaceutical products for treating respiratory diseases and asthma, Pharmaceutical skin lotions, Pharmaceutical solutions used in dialysis, Pharmaceuticals, namely, antihelmintics, Pharmaceuticals, namely, inducers of erections, Pharmaceuticals, namely, lipid lowering agents, Pharmaceuticals, namely, psychotropics, Pharmaceuticals, namely, anti-infectives; Veterinary preparations, namely, pain relief medication, veterinary preparations for the treatment of intestinal bacteria, Veterinary vaccine for horses, Veterinary vaccines; sanitary preparations for medical purposes; dietetic foods adapted for medical use, food for babies; medical plasters, dressings for wounds, burns, surgery; dental impression materials; disinfectants for hygienic purposes; preparations for destroying vermin; fungicides and herbicides * all of the aforementioned products exclusively as intermediates for research and test purposes and in form of recipes *
Scientific and technological services in the nature of research in the field of agrochemicals, pharmaceuticals and bio-chemistry and design services relating thereto, namely, scientific and technological services relating to properties of agrochemicals, pharmaceuticals and bio-chemistry; industrial analysis and research services [ ; design and development of computer hardware and software ]
No 79051641
No Service Mark
No 034341.003
No
No
No
No
No
No
No
No
26.15.13 -
More than one polygon
26.15.16 -
Polygons touching or intersecting
26.15.21 -
Polygons that are completely or partially shaded
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.05 -
Horizontal line(s), band(s) or bar(s)
26.17.07 -
Lines depicting speed, propulsion, heat or wind
Status Date | Action Taken |
---|---|
07th May 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
10th Jul 2020 | TOTAL INVALIDATION PROCESSED BY THE IB |
11th Jun 2020 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
11th Jun 2020 | INVALIDATION PROCESSED |
06th May 2020 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
06th Sep 2019 | CANCELLED SECTION 71 |
03rd Dec 2018 | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE |
22nd Nov 2018 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
19th Jul 2018 | NEW REPRESENTATIVE AT IB RECEIVED |
22nd Mar 2018 | CORRECTION UNDER SECTION 7 ¿ PROCESSED |